Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Column Agglutination Test Cards Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Column Agglutination Test Cards Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-08-05
Pages: 167 Pages
Report ld: 4895801
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Column Agglutination Test Cards market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
The Gel Card Method is based on the principles of agglutination and hemagglutination. Agglutination is the clumping together of particles – in this case, red blood cells (RBCs). The RBCs will agglutinate when mixed with sera containing the corresponding antibodies. The degree of agglutination in the microtubes within the gel card is then used to determine the blood group.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Column Agglutination Test Cards market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Grifols
- Bio-Rad
- Ortho Clinical Diagnostics (QuidelOrtho)
- Turklab
- Tulip Diagnostics (PerkinElmer)
- Redcell Biotechnology
- Dia Pro Tıbbi Ürünler
- Aikang MedTech
- Tianjin Dexiang Biotech
- POLYRICHE BIOTECH
- Hubei Longtime Biological
- Singapore BioSciences
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Blood Grouping Forward and Reverse Test
- Cross Match Test
- Other
Segment by Application
- Hospitals
- Research Centers
- Laboratory
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Column Agglutination Test Cards study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Column Agglutination Test Cards: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Column Agglutination Test Cards Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Blood Grouping Forward and Reverse Test
1.2.3 Cross Match Test
1.2.4 Other
1.3 Market Segmentation by Application
1.3.1 Global Column Agglutination Test Cards Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research Centers
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Column Agglutination Test Cards Revenue Estimates and Forecasts 2020-2031
2.2 Global Column Agglutination Test Cards Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Column Agglutination Test Cards Sales Estimates and Forecasts 2020-2031
2.4 Global Column Agglutination Test Cards Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Column Agglutination Test Cards Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Column Agglutination Test Cards Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Blood Grouping Forward and Reverse Test Market Size by Manufacturers
3.5.2 Cross Match Test Market Size by Manufacturers
3.5.3 Other Market Size by Manufacturers
3.6 Global Column Agglutination Test Cards Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Column Agglutination Test Cards Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Column Agglutination Test Cards Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Column Agglutination Test Cards Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Column Agglutination Test Cards Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Column Agglutination Test Cards Sales and Revenue by Type (2020-2031)
6.4 North America Column Agglutination Test Cards Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Column Agglutination Test Cards Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Column Agglutination Test Cards Sales and Revenue by Type (2020-2031)
7.4 Europe Column Agglutination Test Cards Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Column Agglutination Test Cards Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Column Agglutination Test Cards Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Column Agglutination Test Cards Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Column Agglutination Test Cards Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Column Agglutination Test Cards Sales and Revenue by Type (2020-2031)
9.4 Central and South America Column Agglutination Test Cards Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Column Agglutination Test Cards Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Column Agglutination Test Cards Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Column Agglutination Test Cards Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Column Agglutination Test Cards Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Grifols
11.1.1 Grifols Corporation Information
11.1.2 Grifols Business Overview
11.1.3 Grifols Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.1.4 Grifols Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Grifols Column Agglutination Test Cards Sales by Product in 2024
11.1.6 Grifols Column Agglutination Test Cards Sales by Application in 2024
11.1.7 Grifols Column Agglutination Test Cards Sales by Geographic Area in 2024
11.1.8 Grifols Column Agglutination Test Cards SWOT Analysis
11.1.9 Grifols Recent Developments
11.2 Bio-Rad
11.2.1 Bio-Rad Corporation Information
11.2.2 Bio-Rad Business Overview
11.2.3 Bio-Rad Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.2.4 Bio-Rad Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Bio-Rad Column Agglutination Test Cards Sales by Product in 2024
11.2.6 Bio-Rad Column Agglutination Test Cards Sales by Application in 2024
11.2.7 Bio-Rad Column Agglutination Test Cards Sales by Geographic Area in 2024
11.2.8 Bio-Rad Column Agglutination Test Cards SWOT Analysis
11.2.9 Bio-Rad Recent Developments
11.3 Ortho Clinical Diagnostics (QuidelOrtho)
11.3.1 Ortho Clinical Diagnostics (QuidelOrtho) Corporation Information
11.3.2 Ortho Clinical Diagnostics (QuidelOrtho) Business Overview
11.3.3 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.3.4 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Sales by Product in 2024
11.3.6 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Sales by Application in 2024
11.3.7 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards Sales by Geographic Area in 2024
11.3.8 Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards SWOT Analysis
11.3.9 Ortho Clinical Diagnostics (QuidelOrtho) Recent Developments
11.4 Turklab
11.4.1 Turklab Corporation Information
11.4.2 Turklab Business Overview
11.4.3 Turklab Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.4.4 Turklab Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Turklab Column Agglutination Test Cards Sales by Product in 2024
11.4.6 Turklab Column Agglutination Test Cards Sales by Application in 2024
11.4.7 Turklab Column Agglutination Test Cards Sales by Geographic Area in 2024
11.4.8 Turklab Column Agglutination Test Cards SWOT Analysis
11.4.9 Turklab Recent Developments
11.5 Tulip Diagnostics (PerkinElmer)
11.5.1 Tulip Diagnostics (PerkinElmer) Corporation Information
11.5.2 Tulip Diagnostics (PerkinElmer) Business Overview
11.5.3 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.5.4 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Sales by Product in 2024
11.5.6 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Sales by Application in 2024
11.5.7 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards Sales by Geographic Area in 2024
11.5.8 Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards SWOT Analysis
11.5.9 Tulip Diagnostics (PerkinElmer) Recent Developments
11.6 Redcell Biotechnology
11.6.1 Redcell Biotechnology Corporation Information
11.6.2 Redcell Biotechnology Business Overview
11.6.3 Redcell Biotechnology Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.6.4 Redcell Biotechnology Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Redcell Biotechnology Recent Developments
11.7 Dia Pro Tıbbi Ürünler
11.7.1 Dia Pro Tıbbi Ürünler Corporation Information
11.7.2 Dia Pro Tıbbi Ürünler Business Overview
11.7.3 Dia Pro Tıbbi Ürünler Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.7.4 Dia Pro Tıbbi Ürünler Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Dia Pro Tıbbi Ürünler Recent Developments
11.8 Aikang MedTech
11.8.1 Aikang MedTech Corporation Information
11.8.2 Aikang MedTech Business Overview
11.8.3 Aikang MedTech Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.8.4 Aikang MedTech Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Aikang MedTech Recent Developments
11.9 Tianjin Dexiang Biotech
11.9.1 Tianjin Dexiang Biotech Corporation Information
11.9.2 Tianjin Dexiang Biotech Business Overview
11.9.3 Tianjin Dexiang Biotech Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.9.4 Tianjin Dexiang Biotech Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Tianjin Dexiang Biotech Recent Developments
11.10 POLYRICHE BIOTECH
11.10.1 POLYRICHE BIOTECH Corporation Information
11.10.2 POLYRICHE BIOTECH Business Overview
11.10.3 POLYRICHE BIOTECH Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.10.4 POLYRICHE BIOTECH Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 POLYRICHE BIOTECH Recent Developments
11.11 Hubei Longtime Biological
11.11.1 Hubei Longtime Biological Corporation Information
11.11.2 Hubei Longtime Biological Business Overview
11.11.3 Hubei Longtime Biological Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.11.4 Hubei Longtime Biological Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Hubei Longtime Biological Recent Developments
11.12 Singapore BioSciences
11.12.1 Singapore BioSciences Corporation Information
11.12.2 Singapore BioSciences Business Overview
11.12.3 Singapore BioSciences Column Agglutination Test Cards Product Models, Descriptions and Specifications
11.12.4 Singapore BioSciences Column Agglutination Test Cards Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Singapore BioSciences Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Column Agglutination Test Cards Industry Chain
12.2 Column Agglutination Test Cards Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Column Agglutination Test Cards Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Column Agglutination Test Cards Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Column Agglutination Test Cards Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Column Agglutination Test Cards Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Column Agglutination Test Cards Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Column Agglutination Test Cards Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Column Agglutination Test Cards Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Column Agglutination Test Cards Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Column Agglutination Test Cards Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Column Agglutination Test Cards Sales by Region (2020-2025) & (K Units)
Table 8. Global Column Agglutination Test Cards Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Column Agglutination Test Cards Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Column Agglutination Test Cards Sales Share by Manufacturers (2020-2025)
Table 12. Global Column Agglutination Test Cards Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Column Agglutination Test Cards Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Column Agglutination Test Cards by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Column Agglutination Test Cards as of 2024)
Table 16. Global Column Agglutination Test Cards Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Column Agglutination Test Cards Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Column Agglutination Test Cards Manufacturing Base and Headquarters
Table 19. Global Column Agglutination Test Cards Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Column Agglutination Test Cards Sales by Type (2020-2025) & (K Units)
Table 23. Global Column Agglutination Test Cards Sales by Type (2026-2031) & (K Units)
Table 24. Global Column Agglutination Test Cards Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Column Agglutination Test Cards Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Column Agglutination Test Cards ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Column Agglutination Test Cards Sales by Application (2020-2025) & (K Units)
Table 29. Global Column Agglutination Test Cards Sales by Application (2026-2031) & (K Units)
Table 30. Column Agglutination Test Cards High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Column Agglutination Test Cards Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Column Agglutination Test Cards Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Column Agglutination Test Cards ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Column Agglutination Test Cards Growth Accelerators and Market Barriers
Table 37. North America Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Column Agglutination Test Cards Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Column Agglutination Test Cards Growth Accelerators and Market Barriers
Table 40. Europe Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Column Agglutination Test Cards Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Column Agglutination Test Cards Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Column Agglutination Test Cards Growth Accelerators and Market Barriers
Table 45. Southeast Asia Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Column Agglutination Test Cards Investment Opportunities and Key Challenges
Table 47. Central and South America Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Column Agglutination Test Cards Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Column Agglutination Test Cards Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Grifols Corporation Information
Table 51. Grifols Description and Major Businesses
Table 52. Grifols Product Models, Descriptions and Specifications
Table 53. Grifols Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Grifols Sales Value Proportion by Product in 2024
Table 55. Grifols Sales Value Proportion by Application in 2024
Table 56. Grifols Sales Value Proportion by Geographic Area in 2024
Table 57. Grifols Column Agglutination Test Cards SWOT Analysis
Table 58. Grifols Recent Developments
Table 59. Bio-Rad Corporation Information
Table 60. Bio-Rad Description and Major Businesses
Table 61. Bio-Rad Product Models, Descriptions and Specifications
Table 62. Bio-Rad Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Bio-Rad Sales Value Proportion by Product in 2024
Table 64. Bio-Rad Sales Value Proportion by Application in 2024
Table 65. Bio-Rad Sales Value Proportion by Geographic Area in 2024
Table 66. Bio-Rad Column Agglutination Test Cards SWOT Analysis
Table 67. Bio-Rad Recent Developments
Table 68. Ortho Clinical Diagnostics (QuidelOrtho) Corporation Information
Table 69. Ortho Clinical Diagnostics (QuidelOrtho) Description and Major Businesses
Table 70. Ortho Clinical Diagnostics (QuidelOrtho) Product Models, Descriptions and Specifications
Table 71. Ortho Clinical Diagnostics (QuidelOrtho) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Ortho Clinical Diagnostics (QuidelOrtho) Sales Value Proportion by Product in 2024
Table 73. Ortho Clinical Diagnostics (QuidelOrtho) Sales Value Proportion by Application in 2024
Table 74. Ortho Clinical Diagnostics (QuidelOrtho) Sales Value Proportion by Geographic Area in 2024
Table 75. Ortho Clinical Diagnostics (QuidelOrtho) Column Agglutination Test Cards SWOT Analysis
Table 76. Ortho Clinical Diagnostics (QuidelOrtho) Recent Developments
Table 77. Turklab Corporation Information
Table 78. Turklab Description and Major Businesses
Table 79. Turklab Product Models, Descriptions and Specifications
Table 80. Turklab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Turklab Sales Value Proportion by Product in 2024
Table 82. Turklab Sales Value Proportion by Application in 2024
Table 83. Turklab Sales Value Proportion by Geographic Area in 2024
Table 84. Turklab Column Agglutination Test Cards SWOT Analysis
Table 85. Turklab Recent Developments
Table 86. Tulip Diagnostics (PerkinElmer) Corporation Information
Table 87. Tulip Diagnostics (PerkinElmer) Description and Major Businesses
Table 88. Tulip Diagnostics (PerkinElmer) Product Models, Descriptions and Specifications
Table 89. Tulip Diagnostics (PerkinElmer) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Tulip Diagnostics (PerkinElmer) Sales Value Proportion by Product in 2024
Table 91. Tulip Diagnostics (PerkinElmer) Sales Value Proportion by Application in 2024
Table 92. Tulip Diagnostics (PerkinElmer) Sales Value Proportion by Geographic Area in 2024
Table 93. Tulip Diagnostics (PerkinElmer) Column Agglutination Test Cards SWOT Analysis
Table 94. Tulip Diagnostics (PerkinElmer) Recent Developments
Table 95. Redcell Biotechnology Corporation Information
Table 96. Redcell Biotechnology Description and Major Businesses
Table 97. Redcell Biotechnology Product Models, Descriptions and Specifications
Table 98. Redcell Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Redcell Biotechnology Recent Developments
Table 100. Dia Pro Tıbbi Ürünler Corporation Information
Table 101. Dia Pro Tıbbi Ürünler Description and Major Businesses
Table 102. Dia Pro Tıbbi Ürünler Product Models, Descriptions and Specifications
Table 103. Dia Pro Tıbbi Ürünler Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Dia Pro Tıbbi Ürünler Recent Developments
Table 105. Aikang MedTech Corporation Information
Table 106. Aikang MedTech Description and Major Businesses
Table 107. Aikang MedTech Product Models, Descriptions and Specifications
Table 108. Aikang MedTech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Aikang MedTech Recent Developments
Table 110. Tianjin Dexiang Biotech Corporation Information
Table 111. Tianjin Dexiang Biotech Description and Major Businesses
Table 112. Tianjin Dexiang Biotech Product Models, Descriptions and Specifications
Table 113. Tianjin Dexiang Biotech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Tianjin Dexiang Biotech Recent Developments
Table 115. POLYRICHE BIOTECH Corporation Information
Table 116. POLYRICHE BIOTECH Description and Major Businesses
Table 117. POLYRICHE BIOTECH Product Models, Descriptions and Specifications
Table 118. POLYRICHE BIOTECH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. POLYRICHE BIOTECH Recent Developments
Table 120. Hubei Longtime Biological Corporation Information
Table 121. Hubei Longtime Biological Description and Major Businesses
Table 122. Hubei Longtime Biological Product Models, Descriptions and Specifications
Table 123. Hubei Longtime Biological Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Hubei Longtime Biological Recent Developments
Table 125. Singapore BioSciences Corporation Information
Table 126. Singapore BioSciences Description and Major Businesses
Table 127. Singapore BioSciences Product Models, Descriptions and Specifications
Table 128. Singapore BioSciences Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Singapore BioSciences Recent Developments
Table 130. Key Raw Materials Distribution
Table 131. Raw Materials Key Suppliers
Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 133. Milestones in Production Technology Evolution
Table 134. Distributors List
Table 135. Market Trends and Market Evolution
Table 136. Market Drivers and Opportunities
Table 137. Market Challenges, Risks, and Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Column Agglutination Test Cards Product Picture
Figure 2. Global Column Agglutination Test Cards Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Blood Grouping Forward and Reverse Test Product Picture
Figure 4. Cross Match Test Product Picture
Figure 5. Other Product Picture
Figure 6. Global Column Agglutination Test Cards Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospitals
Figure 8. Research Centers
Figure 9. Laboratory
Figure 10. Others
Figure 11. Column Agglutination Test Cards Report Years Considered
Figure 12. Global Column Agglutination Test Cards Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 14. Global Column Agglutination Test Cards Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Column Agglutination Test Cards Revenue Market Share by Region (2020-2031)
Figure 16. Global Column Agglutination Test Cards Sales (2020-2031) & (K Units)
Figure 17. Global Column Agglutination Test Cards Sales (CAGR) by Region (2020-2031) (K Units)
Figure 18. Global Column Agglutination Test Cards Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Column Agglutination Test Cards Sales Volume Market Share in 2024
Figure 20. Global Column Agglutination Test Cards Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Blood Grouping Forward and Reverse Test Revenue Market Share by Manufacturer in 2024
Figure 23. Cross Match Test Revenue Market Share by Manufacturer in 2024
Figure 24. Other Revenue Market Share by Manufacturer in 2024
Figure 25. Global Column Agglutination Test Cards Sales Market Share by Type (2020-2031)
Figure 26. Global Column Agglutination Test Cards Revenue Market Share by Type (2020-2031)
Figure 27. Global Column Agglutination Test Cards Sales Market Share by Application (2020-2031)
Figure 28. Global Column Agglutination Test Cards Revenue Market Share by Application (2020-2031)
Figure 29. North America Column Agglutination Test Cards Sales YoY (2020-2031) & (K Units)
Figure 30. North America Column Agglutination Test Cards Revenue YoY (2020-2031) & (US$ Million)
Figure 31. North America Top 5 Manufacturers Column Agglutination Test Cards Sales Revenue (US$ Million) in 2024
Figure 32. North America Column Agglutination Test Cards Sales Volume (K Units) by Type (2020- 2031)
Figure 33. North America Column Agglutination Test Cards Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 34. North America Column Agglutination Test Cards Sales Volume (K Units) by Application (2020-2031)
Figure 35. North America Column Agglutination Test Cards Sales Revenue (US$ Million) by Application (2020-2031)
Figure 36. US Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 37. Canada Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 38. Mexico Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 39. Europe Column Agglutination Test Cards Sales YoY (2020-2031) & (K Units)
Figure 40. Europe Column Agglutination Test Cards Revenue YoY (2020-2031) & (US$ Million)
Figure 41. Europe Top 5 Manufacturers Column Agglutination Test Cards Sales Revenue (US$ Million) in 2024
Figure 42. Europe Column Agglutination Test Cards Sales Volume (K Units) by Type (2020-2031)
Figure 43. Europe Column Agglutination Test Cards Sales Revenue (US$ Million) by Type (2020-2031)
Figure 44. Europe Column Agglutination Test Cards Sales Volume (K Units) by Application (2020-2031)
Figure 45. Europe Column Agglutination Test Cards Sales Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 47. France Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 49. Italy Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 50. Russia Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific Column Agglutination Test Cards Sales YoY (2020-2031) & (K Units)
Figure 52. Asia-Pacific Column Agglutination Test Cards Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Top 8 Manufacturers Column Agglutination Test Cards Sales Revenue (US$ Million) in 2024
Figure 54. Asia-Pacific Column Agglutination Test Cards Sales Volume (K Units) by Type (2020- 2031)
Figure 55. Asia-Pacific Column Agglutination Test Cards Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 56. Asia-Pacific Column Agglutination Test Cards Sales Volume (K Units) by Application (2020-2031)
Figure 57. Asia-Pacific Column Agglutination Test Cards Sales Revenue (US$ Million) by Application (2020-2031)
Figure 58. Indonesia Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 59. Japan Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 60. South Korea Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 61. China Taiwan Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 62. India Column Agglutination Test Cards Revenue (2020-2031) & (US$ Million)
Figure 63. Central and South America Column Agglutination Test Cards Sales YoY (2020-2031) & (K Units)
Figure 64. Central and South America Column Agglutination Test Cards Revenue YoY (2020-2031) & (US$ Million)
Figure 65. Central and South America Top 5 Manufacturers Column Agglutination Test Cards Sales Revenue (US$ Million) in 2024
Figure 66. Central and South America Column Agglutination Test Cards Sales Volume (K Units) by Type (2021-2031)
Figure 67. Central and South America Column Agglutination Test Cards Sales Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America Column Agglutination Test Cards Sales Volume (K Units) by Application (2020-2031)
Figure 69. Central and South America Column Agglutination Test Cards Sales Revenue (US$ Million) by Application (2020-2031)
Figure 70. Brazil Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 71. Argentina Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 72. Middle East, and Africa Column Agglutination Test Cards Sales YoY (2020-2031) & (K Units)
Figure 73. Middle East and Africa Column Agglutination Test Cards Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Middle East and Africa Top 5 Manufacturers Column Agglutination Test Cards Sales Revenue (US$ Million) in 2024
Figure 75. Middle East and Africa Column Agglutination Test Cards Sales Volume (K Units) by Type (2021-2031)
Figure 76. South America Column Agglutination Test Cards Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Middle East and Africa Column Agglutination Test Cards Sales Volume (K Units) by Application (2020-2031)
Figure 78. Middle East and Africa Column Agglutination Test Cards Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. GCC Countries Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 80. Turkey Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 81. Egypt Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 82. South Africa Column Agglutination Test Cards Revenue (2020-2025) & (US$ Million)
Figure 83. Column Agglutination Test Cards Industry Chain Mapping
Figure 84. Regional Column Agglutination Test Cards Manufacturing Base Distribution (%)
Figure 85. Global Column Agglutination Test Cards Production Market Share by Region (2020-2031)
Figure 86. Column Agglutination Test Cards Production Process
Figure 87. Regional Column Agglutination Test Cards Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Column Agglutination Test Cards market?
The top companies in the global Column Agglutination Test Cards market are Grifols、Bio-Rad、Ortho Clinical Diagnostics (QuidelOrtho).
Related Reports
Global Column Agglutination Test Cards Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Column Agglutination Test Cards market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-27
Pages: 168
USD 4900.00
(Single User License)
Global Column Agglutination Test Cards Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Column Agglutination Test Cards market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-27
Pages: 92
USD 4250.00
(Single User License)
Column Agglutination Test Cards- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Column Agglutination Test Cards was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 119
USD 3950.00
(Single User License)
Global Column Agglutination Test Cards Market Research Report 2026
The global Column Agglutination Test Cards market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-15
Pages: 123
USD 2900.00
(Single User License)
Global Column Agglutination Test Cards Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Column Agglutination Test Cards market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 94
USD 4250.00
(Single User License)
Column Agglutination Test Cards - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Column Agglutination Test Cards was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 114
USD 3950.00
(Single User License)
Global Column Agglutination Test Cards Market Research Report 2025
The global market for Column Agglutination Test Cards was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 97
USD 2900.00
(Single User License)
Global Column Agglutination Test Cards Market Insights, Forecast to 2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published Date: 2024-05-30
Pages: 154
USD 4900.00
(Single User License)
Global and China Column Agglutination Test Cards Market Report & Forecast 2024-2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published Date: 2024-05-30
Pages: 122
USD 4350.00
(Single User License)
Column Agglutination Test Cards- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published Date: 2024-05-30
Pages: 122
USD 3950.00
(Single User License)
Global Column Agglutination Test Cards Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Column Agglutination Test Cards market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-27
Pages: 168
USD 4900.00 (Single User License)Global Column Agglutination Test Cards Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Column Agglutination Test Cards market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-27
Pages: 92
USD 4250.00 (Single User License)Column Agglutination Test Cards- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Column Agglutination Test Cards was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 119
USD 3950.00 (Single User License)Global Column Agglutination Test Cards Market Research Report 2026
The global Column Agglutination Test Cards market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-15
Pages: 123
USD 2900.00 (Single User License)Global Column Agglutination Test Cards Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Column Agglutination Test Cards market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 94
USD 4250.00 (Single User License)Column Agglutination Test Cards - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Column Agglutination Test Cards was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 114
USD 3950.00 (Single User License)Global Column Agglutination Test Cards Market Research Report 2025
The global market for Column Agglutination Test Cards was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 97
USD 2900.00 (Single User License)Global Column Agglutination Test Cards Market Insights, Forecast to 2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published: 2024-05-30
Pages: 154
USD 4900.00 (Single User License)Global and China Column Agglutination Test Cards Market Report & Forecast 2024-2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published: 2024-05-30
Pages: 122
USD 4350.00 (Single User License)Column Agglutination Test Cards- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
A Column Agglutination Test (CAT) card is a diagnostic tool used primarily in immunohematology to perform blood typing, antibody screening, and cross-matching. It employs a method similar to microcolumn gel cards, where agglutination (clumping) reactions are used to identify specific antigens or antibodies in blood samples.
Published: 2024-05-30
Pages: 122
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now